New breathing method could ease preemie lung care

NCT ID NCT07418502

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a new breathing support called Pressure Targeted High Flow works as well as standard CPAP in premature infants with breathing problems. About 78 babies born before 33 weeks will try each method for 24 hours. Researchers will monitor breathing, oxygen needs, and comfort to see if the new approach is a good alternative.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Pressure Targeted High Flow (a breathing support procedure)
What this could lead to
If it works, this could offer a more comfortable breathing support option for premature infants that is easier for staff to manage.
What could go wrong
This is a small, early-phase trial with only 78 infants, so results may not apply to all preemies. The new method might not provide enough support, leading to breathing failure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BPD - BRONCHOPULMONARY DYSPLASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ascension Seton Medical Center

    Austin, Texas, 78705, United States

  • Sharp Mary Birch Hospital for Women & Newborns

    San Diego, California, 92123, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.